Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

NCCN’s Cancer Treatment Guidelines To Add Drug Cost Considerations

This article was originally published in The Pink Sheet Daily

Executive Summary

The National Comprehensive Cancer Network’s concept of drug affordability will include estimates of the overall expense of providing an intervention, including whether it requires inpatient administration or whether it is infused or oral.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register